Clearside Biomedical IncNASDAQ:CLSD
- LAST PRICE1.5100
- TODAY'S CHANGE (%)0.0200 (1.3423%)
- Bid / Lots1.5000/ 1
- Ask / Lots1.5500/ 3
- Open / Previous Close1.5300 / 1.4900
- Day Range
- 52 Week Range
- Volume411,484
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CLSD |
|---|---|---|
| 09:32 ET | 18924 | 1.56 |
| 09:33 ET | 31975 | 1.6047 |
| 09:35 ET | 5800 | 1.5902 |
| 09:37 ET | 2094 | 1.5566 |
| 09:39 ET | 583 | 1.56 |
| 09:42 ET | 10396 | 1.52 |
| 09:44 ET | 1400 | 1.5597 |
| 09:48 ET | 1020 | 1.57 |
| 09:50 ET | 15705 | 1.6098 |
| 09:53 ET | 15210 | 1.6001 |
| 09:55 ET | 2081 | 1.6 |
| 09:57 ET | 5700 | 1.585 |
| 10:00 ET | 1100 | 1.5701 |
| 10:02 ET | 1000 | 1.5999 |
| 10:04 ET | 4979 | 1.5999 |
| 10:06 ET | 10196 | 1.5997 |
| 10:08 ET | 500 | 1.605 |
| 10:09 ET | 3702 | 1.61 |
| 10:11 ET | 3691 | 1.61 |
| 10:13 ET | 3000 | 1.59 |
| 10:15 ET | 1200 | 1.59 |
| 10:18 ET | 500 | 1.6 |
| 10:22 ET | 400 | 1.6082 |
| 10:26 ET | 432 | 1.605 |
| 10:27 ET | 300 | 1.6 |
| 10:31 ET | 1712 | 1.5986 |
| 10:33 ET | 200 | 1.6 |
| 10:36 ET | 5930 | 1.58 |
| 10:38 ET | 10960 | 1.54 |
| 10:40 ET | 700 | 1.56 |
| 10:42 ET | 1791 | 1.5691 |
| 10:44 ET | 200 | 1.54 |
| 10:45 ET | 1500 | 1.5582 |
| 10:47 ET | 200 | 1.5557 |
| 10:49 ET | 310 | 1.5515 |
| 10:54 ET | 1100 | 1.535 |
| 10:56 ET | 7888 | 1.56 |
| 10:58 ET | 1500 | 1.5699 |
| 11:00 ET | 850 | 1.5699 |
| 11:03 ET | 100 | 1.5758 |
| 11:05 ET | 1000 | 1.56 |
| 11:07 ET | 100 | 1.5602 |
| 11:09 ET | 100 | 1.5917 |
| 11:12 ET | 350 | 1.5877 |
| 11:14 ET | 1000 | 1.5891 |
| 11:16 ET | 900 | 1.57 |
| 11:18 ET | 10626 | 1.57 |
| 11:20 ET | 1903 | 1.54 |
| 11:21 ET | 400 | 1.54 |
| 11:23 ET | 16318 | 1.579 |
| 11:25 ET | 300 | 1.57 |
| 11:27 ET | 1700 | 1.58 |
| 11:32 ET | 300 | 1.58 |
| 11:34 ET | 100 | 1.58 |
| 11:36 ET | 6500 | 1.58 |
| 11:38 ET | 200 | 1.565 |
| 11:39 ET | 3300 | 1.5582 |
| 11:41 ET | 1200 | 1.54 |
| 11:43 ET | 100 | 1.54 |
| 11:50 ET | 1389 | 1.54 |
| 11:52 ET | 5492 | 1.55 |
| 11:54 ET | 6700 | 1.56 |
| 11:56 ET | 1000 | 1.58 |
| 11:57 ET | 800 | 1.5727 |
| 11:59 ET | 700 | 1.57 |
| 12:06 ET | 2400 | 1.5686 |
| 12:08 ET | 1483 | 1.57 |
| 12:12 ET | 200 | 1.555 |
| 12:14 ET | 300 | 1.535 |
| 12:15 ET | 200 | 1.52 |
| 12:17 ET | 200 | 1.535 |
| 12:19 ET | 422 | 1.547 |
| 12:21 ET | 200 | 1.535 |
| 12:24 ET | 1600 | 1.54 |
| 12:26 ET | 302 | 1.54 |
| 12:28 ET | 200 | 1.535 |
| 12:32 ET | 1312 | 1.54 |
| 12:33 ET | 1239 | 1.55 |
| 12:35 ET | 650 | 1.555 |
| 12:39 ET | 100 | 1.555 |
| 12:48 ET | 1541 | 1.5584 |
| 12:51 ET | 200 | 1.545 |
| 12:53 ET | 4994 | 1.53 |
| 12:57 ET | 200 | 1.55 |
| 01:00 ET | 100 | 1.54 |
| 01:02 ET | 278 | 1.54 |
| 01:04 ET | 797 | 1.54 |
| 01:06 ET | 200 | 1.53 |
| 01:08 ET | 100 | 1.53 |
| 01:09 ET | 600 | 1.535 |
| 01:13 ET | 1300 | 1.53 |
| 01:15 ET | 2400 | 1.53 |
| 01:18 ET | 1150 | 1.53 |
| 01:22 ET | 200 | 1.535 |
| 01:24 ET | 5100 | 1.54 |
| 01:31 ET | 750 | 1.53 |
| 01:33 ET | 1211 | 1.53 |
| 01:36 ET | 100 | 1.53 |
| 01:38 ET | 17755 | 1.53 |
| 01:40 ET | 100 | 1.54 |
| 01:49 ET | 5443 | 1.54 |
| 01:51 ET | 112 | 1.545 |
| 02:00 ET | 100 | 1.54 |
| 02:02 ET | 100 | 1.54 |
| 02:03 ET | 100 | 1.54 |
| 02:05 ET | 852 | 1.54 |
| 02:07 ET | 500 | 1.535 |
| 02:09 ET | 200 | 1.535 |
| 02:12 ET | 200 | 1.53 |
| 02:14 ET | 700 | 1.53 |
| 02:16 ET | 200 | 1.52 |
| 02:18 ET | 800 | 1.52 |
| 02:20 ET | 200 | 1.525 |
| 02:21 ET | 200 | 1.525 |
| 02:23 ET | 1180 | 1.525 |
| 02:25 ET | 100 | 1.525 |
| 02:27 ET | 3000 | 1.52 |
| 02:32 ET | 100 | 1.525 |
| 02:34 ET | 2700 | 1.5209 |
| 02:36 ET | 100 | 1.5291 |
| 02:38 ET | 1658 | 1.5299 |
| 02:39 ET | 400 | 1.52 |
| 02:41 ET | 4690 | 1.525 |
| 02:43 ET | 100 | 1.52 |
| 02:45 ET | 400 | 1.52 |
| 02:48 ET | 200 | 1.52 |
| 02:50 ET | 300 | 1.52 |
| 02:52 ET | 300 | 1.52 |
| 02:54 ET | 200 | 1.52 |
| 02:56 ET | 400 | 1.52 |
| 02:57 ET | 200 | 1.52 |
| 02:59 ET | 300 | 1.52 |
| 03:01 ET | 300 | 1.52 |
| 03:03 ET | 100 | 1.52 |
| 03:06 ET | 300 | 1.52 |
| 03:08 ET | 400 | 1.515 |
| 03:10 ET | 1300 | 1.51 |
| 03:14 ET | 100 | 1.51 |
| 03:15 ET | 301 | 1.505 |
| 03:17 ET | 300 | 1.5 |
| 03:19 ET | 500 | 1.4915 |
| 03:21 ET | 1600 | 1.5 |
| 03:24 ET | 1944 | 1.495 |
| 03:26 ET | 200 | 1.495 |
| 03:28 ET | 3018 | 1.48 |
| 03:30 ET | 698 | 1.485 |
| 03:32 ET | 3300 | 1.49 |
| 03:35 ET | 657 | 1.5 |
| 03:37 ET | 300 | 1.49 |
| 03:39 ET | 200 | 1.49 |
| 03:42 ET | 200 | 1.49 |
| 03:44 ET | 2246 | 1.49 |
| 03:46 ET | 2396 | 1.48 |
| 03:48 ET | 2000 | 1.485 |
| 03:50 ET | 8890 | 1.51 |
| 03:51 ET | 6250 | 1.52 |
| 03:53 ET | 1400 | 1.52 |
| 03:55 ET | 2800 | 1.53 |
| 03:57 ET | 1800 | 1.52 |
| 04:00 ET | 4717 | 1.51 |
Yesterday
Feb 2, 2023
--Wedbush Adjusts Clearside Biomedical Price Target to $4 From $6, Maintains Outperform Rating, from 11:43AM ET on Thursday Feb 02, 2023 by MT Newswires
11:43AM ET on Thursday Feb 02, 2023 by MT NewswiresClearside Biomedical Reports Positive Results in Wet AMD Trial; Shares Rise, from 11:27AM ET on Thursday Feb 02, 2023 by MT Newswires
11:27AM ET on Thursday Feb 02, 2023 by MT NewswiresBRIEF-Clearside Biomedical Has About $48.3 Mln Of Cash, Cash Equivalents, from 9:31AM ET on Thursday Feb 02, 2023 by Thomson Reuters
9:31AM ET on Thursday Feb 02, 2023 by Thomson ReutersBRIEF-Clearside Biomedical Announces 6-Month Results From Oasis Extension Study , from 8:22AM ET on Thursday Feb 02, 2023 by Thomson Reuters
8:22AM ET on Thursday Feb 02, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Clearside Biomedical Inc | 89.7M | -15.0x | --- |
Homology Medicines Inc | 95.4M | -18.5x | --- |
Mediwound Ltd | 81.5M | -3.7x | --- |
Syros Pharmaceuticals Inc | 103.6M | -0.3x | --- |
Jounce Therapeutics Inc | 62.6M | -0.5x | --- |
Sesen Bio Inc | 119.2M | -34.9x | --- |
Company Information
Clearside Biomedical, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering therapies to the back of the eye diseases through the suprachoroidal space (SCS). Its SCS injection platform utilizing its SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted delivery of a variety of therapies to the macula, retina or choroid to preserve and improve vision in patients with sight-threatening eye diseases. It is focused on developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector, and it also partners with companies developing other ophthalmic therapeutics to be administered using its SCS injection platform. Its lead product candidate, XIPERE, is a preservative-free suspension of the corticosteroid triamcinolone acetonide (TA), formulated for administration through suprachoroidal injection. Its pipeline includes CLS-AX, CLS-301 and Gene Therapy.
Contact Information
- Headquarters
- 900 North Point Parkway, Suite 200ALPHARETTA, GA, United States 30005
- Phone
- 678-270-3631
- Fax
- 678-270-4033
Executives
- Independent Chairman of the Board
- William Humphries
- President, Chief Executive Officer, Director
- George Lasezkay
- Chief Financial Officer
- Charles Deignan
- Chief Medical Officer, Chief Development Officer
- Thomas Ciulla
- Chief Clinical Officer
- Susan Coultas
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $90.9M |
|---|---|
Revenue (TTM) | $26.7M |
Shares Outstanding | 60.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.95 |
EPS | $-0.10 |
Book Value | $0.64 |
P/E Ratio | -15.0x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
